AIMedInfo Reviews

MedAffairs AI, a cloud-based machine learning tool powered by AI, is specifically designed to improve the Medical Affairs function in the pharmaceutical industry. It is trained on the largest collection of medical affairs data and provides rapid and accurate answers to user queries. This reduces the time spent searching shared drives and folders. The platform allows users to easily retrieve answers using their internal resources, such as clinical studies, standard operational procedures, and articles. Each response is accompanied with the corresponding source documents for easy reference. MedAffairs AI provides comprehensive insights into medical data, regulatory affairs and compliance, key opinion leaders engagement, medical strategy and planning, and medical strategy and planning.

Dr.Evidence, an AI-enabled platform for landscape intelligence, is designed to drive dramatic efficiency across clinical, regulatory and labeling teams. It also helps to improve market access and medical affairs. This allows life sciences companies to quickly bring their products to the market and maintain their market presence. The platform encourages collaboration and decision-making by connecting teams from different departments, therapeutic areas and geographies to a single source of scientific truth. Dr.Evidence, built on augmented intelligence and a combination of human knowledge and AI that is fit for purpose, accelerates insights by generating AI interfaces to summarize content and answer questions. It provides powerful scientific search capabilities for diverse content sets using over 25 robust large-language, machine learning, natural language processing, and other models. Users can quickly analyze different content sets in order to get a 360-degree overview of the landscape.